New monitor may predict heart danger during nose surgery
NCT ID NCT07435870
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether a device called the Analgesia Nociception Index (ANI) can predict and prevent a sudden drop in heart rate (trigeminal cardiac reflex) during nasal septoplasty. 90 adults undergoing nose surgery will be monitored either with standard tools or with the ANI device. The goal is to see if ANI-guided care reduces the risk of this reflex and improves safety during surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Analgesia Nociception Index (ANI) monitoring device
- What this could lead to
- If successful, this could give surgeons a tool to predict and prevent dangerous heart rate drops during nasal surgery, making the procedure safer.
- What could go wrong
- This is a small, early-stage study (90 people) that only tests a monitoring device, not a treatment. It may not prove that ANI monitoring actually prevents complications in routine practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENT DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fayoum univeristy hospital
Al Fayyum, Faiyum Governorate, 63514, Egypt